Aquatic Capital Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-15,694
| Closed | -$320K | – | 1336 |
|
|
2024
Q4 | $320K | Buy |
+15,694
| New | +$320K | 0.01% | 831 |
|
|
2024
Q1 | – | Sell |
-8,300
| Closed | -$178K | – | 1308 |
|
|
2023
Q4 | $178K | Sell |
8,300
-10,000
| -55% | -$214K | ﹤0.01% | 873 |
|
|
2023
Q3 | $378K | Buy |
18,300
+16,300
| +815% | +$337K | 0.02% | 541 |
|
|
2023
Q2 | $59K | Sell |
2,000
-1,800
| -47% | -$53.1K | ﹤0.01% | 957 |
|
|
2023
Q1 | $88K | Buy |
+3,800
| New | +$88K | 0.01% | 778 |
|
|
2022
Q2 | – | Sell |
-1,100
| Closed | -$35K | – | 1278 |
|
|
2022
Q1 | $35K | Buy |
+1,100
| New | +$35K | 0.05% | 358 |
|